The use of kisspeptin as a novel physiological trigger for oocyte maturation in IVF treatment
Background: Infertility affects one in six couples (1) and hence is an important health issue, which can have significant medical, psychological and financial implications for couples. In vitro fertilization (IVF) is an effective treatment for infertility. However, one of the major complications tha...
Main Author: | Islam, Rumana |
---|---|
Other Authors: | Dhillo, Waljit ; Trew, Geoffrey |
Published: |
Imperial College London
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733258 |
Similar Items
-
The use of kisspeptin as a novel physiological oocyte maturation trigger for patients undergoing IVF treatment
by: Christopoulos, Georgios
Published: (2015) -
OOCYTE FINAL MATURATION TRIGGERS IN IVF PROGRAMS
by: E. B. Rudakova
Published: (2016-12-01) -
Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment
by: Ali Abbara, et al.
Published: (2020-10-01) -
Effect of kisspeptin on in vitro maturation of sheep oocytes
by: Priyanka Byri, et al.
Published: (2017-03-01) -
Studies of asymmetric oocyte division and new genes controlling oocyte maturation
by: Pfender, Sybille Helen
Published: (2013)